Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 157–157 | Cite as

Ipilimumab

Elevation in aspartate aminotransferase: case report
Case report
  • 21 Downloads

Reference

  1. Polkowska M, et al. Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients-real-world data. European Journal of Clinical Pharmacology 75: 329-334, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1007/s00228-018-2590-6 - PolandCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations